1. Home
  2. BAFN vs PLUR Comparison

BAFN vs PLUR Comparison

Compare BAFN & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$6.15

Market Cap

30.9M

Sector

Finance

ML Signal

N/A

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.52

Market Cap

36.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAFN
PLUR
Founded
1999
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
36.2M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
BAFN
PLUR
Price
$6.15
$3.52
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
13.3K
10.5K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
1.28%
N/A
EPS Growth
133.93
10.78
EPS
N/A
N/A
Revenue
N/A
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
309.82
52 Week Low
$5.72
$2.82
52 Week High
$19.15
$7.13

Technical Indicators

Market Signals
Indicator
BAFN
PLUR
Relative Strength Index (RSI) 42.80 50.05
Support Level $6.31 $3.50
Resistance Level $8.26 $3.85
Average True Range (ATR) 0.35 0.19
MACD -0.06 -0.03
Stochastic Oscillator 22.69 53.13

Price Performance

Historical Comparison
BAFN
PLUR

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: